BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11683796)

  • 1. Trends in quinolone susceptibility of Enterobacteriaceae among inpatients of a large university hospital: 1992-98.
    Robert J; Cambau E; Grenet K; Trystram D; Péan Y; Fiévet MH; Jarlier V
    Clin Microbiol Infect; 2001 Oct; 7(10):553-61. PubMed ID: 11683796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evolution of susceptibility of aerobic gram-negative aerobic bacilli to quinolones and fluoroquinolones in a university hospital (1992-2000)].
    Trystram D; Grenet K; Cambau E; Péan Y; Fiévet MH; Jarlier V; Robert J
    Pathol Biol (Paris); 2002 Feb; 50(1):30-7. PubMed ID: 11873626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of mutations in the gyrA and parC genes in quinolone-resistant clinical isolates of Enterobacter cloacae.
    Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Nishino Y; Ishihara S; Kawada Y
    J Antimicrob Chemother; 1997 Oct; 40(4):543-9. PubMed ID: 9372424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic characterization of quinolone-resistant mutants of Enterobacteriaceae selected from wild type, gyrA type and multiply-resistant (marA) type strains.
    Piddock LJ; Hall MC; Walters RN
    J Antimicrob Chemother; 1991 Aug; 28(2):185-98. PubMed ID: 1663926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevalence of qnr genes in clinical Enterobacteriaceae non-susceptible to fluoroquinolone in Poland].
    Piekarska K; Rzeczkowska M; Zacharczuk K; Chróst A; Januszkiewicz A; Bareja E; Olak M; Gierczyński R
    Med Dosw Mikrobiol; 2012; 64(3):211-9. PubMed ID: 23285775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validity of nalidixic acid screening in fluoroquinolone-resistant typhoid salmonellae.
    Butt T; Khan MY; Ahmad RN; Salman M; Afzal RK
    J Coll Physicians Surg Pak; 2006 Jan; 16(1):31-4. PubMed ID: 16441985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
    King A; Phillips I
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():1-20. PubMed ID: 3468100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of Enterobacteriaceae to beta-lactam agents and fluoroquinolones: a 3-year survey in France.
    Sirot J; Nicolas-Chanoine MH; Chardon H; Avril JL; Cattoen C; Croix JC; Dabernat H; Fosse T; Ghnassia JC; Lecaillon E; Marmonier A; Roussel-Delvallez M; Soussy CJ; Trevoux A; Vandenesch F; Dib C; Moniot-Ville N; Rezvani Y
    Clin Microbiol Infect; 2002 Apr; 8(4):207-13. PubMed ID: 12047412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of garenoxacin tested against a worldwide collection of ciprofloxacin-susceptible and ciprofloxacin-resistant Enterobacteriaceae strains (1999-2004).
    Sader HS; Fritsche TR; Jones RN
    Diagn Microbiol Infect Dis; 2007 May; 58(1):27-32. PubMed ID: 17383140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Activity of Fosfomycin Against Extended-Spectrum Beta-Lactamase-Producing Isolates of Enterobacteriaceae Recovered from Urinary Tract Infections: A Single-Center Study Over a Period of 12 Years.
    Aris P; Boroumand MA; Rahbar M; Douraghi M
    Microb Drug Resist; 2018 Jun; 24(5):607-612. PubMed ID: 29064348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of resistance to nalidixic acid and the fluoroquinolones after the introduction of norfloxacin and ofloxacin.
    Kresken M; Wiedemann B
    Antimicrob Agents Chemother; 1988 Aug; 32(8):1285-8. PubMed ID: 3142353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of plasmid-mediated quinolone resistance determinants in ESBL Enterobacteriaceae clinical isolates over a 1-year period in a French hospital.
    Crémet L; Caroff N; Dauvergne S; Reynaud A; Lepelletier D; Corvec S
    Pathol Biol (Paris); 2011 Jun; 59(3):151-6. PubMed ID: 19481883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro activity of newer quinolones against aerobic bacteria.
    Auckenthaler R; Michéa-Hamzehpour M; Pechère JC
    J Antimicrob Chemother; 1986 Apr; 17 Suppl B():29-39. PubMed ID: 2940214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative bacteriologic activity of norfloxacin, ofloxacin and pefloxacin against 320 Gram-negative bacilli resistant and non-resistant to nalidixic acid and cephalosporins].
    Croize J; Le Noc P; Bryskier A; Robert J
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):564-8. PubMed ID: 3937128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of nalidixic acid resistant, ciprofloxacin susceptible phenotype among clinical isolates of Escherichia coli and other Enterobacteriaceae.
    Ruiz J; Gómez J; Navia MM; Ribera A; Sierra JM; Marco F; Mensa J; Vila J
    Diagn Microbiol Infect Dis; 2002 Apr; 42(4):257-61. PubMed ID: 12007443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of mutation distribution in DNA gyrase and topoisomerase IV genes in ciprofloxacin-non-susceptible Enterobacteriaceae isolated from blood cultures in a tertiary care university hospital in South Korea, 2005-2010.
    Nam YS; Cho SY; Yang HY; Park KS; Jang JH; Kim YT; Jeong JW; Suh JT; Lee HJ
    Int J Antimicrob Agents; 2013 Feb; 41(2):126-9. PubMed ID: 23265914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Investigation of plasmid-mediated quinolone resistance determinants in Enterobacteriaceae: a multicenter study].
    Coban AY; Nohut OK; Tanrıverdi Çaycı Y; Bayramoğlu G; Pirinççiler M; Cetinkaya E; Cekiç Cihan C; Bozdoğan B; Durupınar B
    Mikrobiyol Bul; 2012 Jul; 46(3):366-74. PubMed ID: 22951649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of mutations in target genes in septicemia isolates of Escherichia coli and Klebsiella pneumoniae with resistance or reduced susceptibility to ciprofloxacin.
    Fendukly F; Karlsson I; Hanson HS; Kronvall G; Dornbusch K
    APMIS; 2003 Sep; 111(9):857-66. PubMed ID: 14510643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Plasmid-Mediated Quinolone Resistance Determinants in High-Level Quinolone-Resistant Enterobacteriaceae Isolates from the Community: First Report of qnrD Gene in Algeria.
    Yanat B; Machuca J; Díaz-De-Alba P; Mezhoud H; Touati A; Pascual Á; Rodríguez-Martínez JM
    Microb Drug Resist; 2017 Jan; 23(1):90-97. PubMed ID: 27115732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Growing incidence of nalidixic acid resistance and sensitivity to quinolones in Salmonella typhimurium strains isolated from man or animal].
    Heurtin-Le Corre C; Donnio PY; Bonnier M; Travert MF; Lacourt A; Avril JL
    Pathol Biol (Paris); 1998 Oct; 46(8):587-90. PubMed ID: 9871929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.